期刊文献+

卵巢上皮性肿瘤中溶血磷脂酸受体表达及其生物学意义 被引量:2

Clinical significance of expression of lysophosphatidic acid receptors in epithelial ovarian neoplasms
暂未订购
导出
摘要 目的:探讨3种溶血磷脂酸(lysophosphatidic acid,LPA)受体(LPA1,LPA2及LPA3)mRNA和蛋白在人卵巢肿瘤组织中的表达状况及意义。方法:采用半定量RT-PCR和Western blot检测LPA1、LPA2和LPA3mRNA以及LPA2和LPA3蛋白在人卵巢上皮性肿瘤组织中的表达水平。结果:RT-PCR结果显示,LPA1mRNA在正常卵巢组织、良性卵巢肿瘤及上皮性卵巢癌中表达阳性率分别为100%、100%、95.7%,差异均无显著性(P>0.05);上皮性卵巢癌组织LPA2mRNA、LPA3mRNA表达阳性率(95.7%;91.3%)显著高于良性卵巢肿瘤(21.3%;21.3%)及正常卵巢组织(15.4%;15.4%)(P<0.01);良性卵巢肿瘤与正常卵巢组织LPA2mRNA、LPA3mRNA表达阳性率差异无显著性(P>0.05);上皮性卵巢癌组织中LPA1mRNA表达率和表达水平高于LPA3mRNA(P<0.05)。Western blot结果显示,上皮性卵巢癌组织中LPA2和LPA3蛋白表达阳性率(95.7%;95.7%)均高于良性卵巢肿瘤(50%;42.9%)和正常卵巢组织表达阳性率(38.5%;38.5%)(P<0.01);良性卵巢肿瘤与正常卵巢组织中LPA2和LPA3蛋白表达阳性率及表达水平相比差异无显著性(P>0.05)。病理资料的相关分析显示,上皮性卵巢癌组织中LPA受体mRNA和蛋白表达与临床病理特征无相关性。结论:LPA1、LPA2和LPA3在卵巢上皮性肿瘤中普遍表达,LPA受体可能参与了卵巢癌的发生发展过程。 Objective: To investigate the lysophosphatidic acid (LPA) receptors expression and their biological significance in human epithelial ovarian neoplasms. Methods: The reverse transcription polymerase chain reation (RT PCR) and Western blot were employed to measure the expression of LPA-1,LPA-2,and LPA 3 receptor mRNA and LPA-2 and LPA-3 receptor protein expression in human epithelial ovarian neoplasms. Results: 1)The positive rate of LPA-1 receptor mRNA in normal ovarian tissue, ovarian benign disease, and ovarian cancer was 100 %, 100 %, and 95.7 %, respectively. The difference was not significant between them(P〉0.05). The positive rates of LPA-2 and LPA 3 receptor mRNA (95.7 % and 91.3 %) were significantly higher in epithelial ovarian neoplasms than in ovarian benign disease (21.3% and 21. 3%) and normal ovarian tissue (15. 4% and 15.4%). The positive rates of LPA-2 and LPA-3 receptor mRNA had no significant difference between ovarian benign disease and normal ovarian tissue(P;〉0.05). The mRNA expression of LPA-1 receptor was markedly higher than LPA 3 receptor in epithelial ovarian neoplasms(P〈0.05). 2)Western blot revealed that the positive rates and expression level of LPA. 2 and LPA-3 receptor protein were significantly increased in epithelial ovarian neoplasms compared with ovarian benign disease and normal ovarian tissue (95.7% and 95.7% vs 38.5% and 38.5% ,P〈0.01). The positive rates and expression level of LPA-2 and LPA- 3 receptor protein had no significant difference between ovarian benign disease and normal ovarian tissue(P〉0.05). 3)No significant correlation was found between LPA receptor expression and clinicopathological features. Conclusion: LPA1, LPA2, and LPA-3 receptors were highly expressed in human epithelial ovarian neoplasms. LPA receptors may be involved in the development and progression of human ovarian cancer.
出处 《肿瘤》 CAS CSCD 北大核心 2006年第3期289-292,305,共5页 Tumor
关键词 卵巢肿瘤 溶血磷脂酸 受体 基因表达 Ovarian neoplasms Lysophosphatidie acid Receptor Gene expression
  • 相关文献

参考文献12

  • 1XU Y, GAUDETTE D C, BPYNTON J D, et al. Characterization of an ovarion cancer activating in ascites from ovarion cancer patients[J]. Clin Cancer Res, 1995,1 :1223-1313.
  • 2SHIDA D, KITAYAMA J, YAMAGUCHI H, et al. Lysophosphatidic acid enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1 [J]. Cancer Res, 2003,63(7) : 1706-1711.
  • 3FISHMAN D A, LIU Y, SHAWN M, et al. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarion cancer cells [J]. Cancer Res ,2001,61(7) :3194-3199.
  • 4HU Y L, TEE M K, GOETZL E J, et al. Lysophosphatidie acidinduction of vascular endothelial growth factor expression inhuman ovarian cancer cells[J]. J Natl Cancer Inst, 2001,93762-768.
  • 5GORDON B M, WOUTER H M. The emerging role of lysophosphatidic acid in cancer[J]. Nature, 2003,3 : 582-591.
  • 6FANG X, YU S X, ROBERT C, et al. Meehanisms for Lysophosphatidic acid-induced cytokion production in ovarian cancer cells[J]. J Biol Chem ,2004,279(10) :9651-9661.
  • 7FURUI T,LAPUSHIN R,MAO M,et al. Overexpression of Edg-2/vzg 1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid independent manner[J]. Clin Cancer Res, 1999,5 : 4308-4318.
  • 8HUANG MC,GRAELER MS,HANLAR G,et al. Lysophospholipid mediators of immunity and neoplasia[J]. Biochim Bio phys Acta,2002,1582(1-3),161-167.
  • 9YAMADA T,SATO K,KOMACH M,et al. Lysophosphatidic acid(LPA) in malignant ascites stimulates motility of humanpan creatic cancer cells through LPA:[J]. Biol Chem, 2004,279(8) :6595-6605.
  • 10SHIDA D, WATANABE T, AOKI J, et al. Aberrant expression of lysophosphatidic acid receptors in human colorectal cancer[J]. Lab Invest, 2004,1-11.

同被引文献33

  • 1吴小华,王小玲,张立芳,李利,王永军,郭燕红,郭清,杨波,黎海莉.卵巢上皮性肿瘤组织中间皮素和CA_(125)表达及其相关性研究[J].中华妇产科杂志,2005,40(10):709-711. 被引量:16
  • 2汪萍,吴小华,陈文雪,赵喜庆.溶血磷脂酸对人卵巢癌细胞基质金属蛋白酶-2、9蛋白表达的影响[J].肿瘤,2006,26(9):819-822. 被引量:3
  • 3Wang P, Wu X, Chen W, et al. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms[J]. Gynecol Oncol, 2007,104(3):714- 720.
  • 4Simon M F, Daviaud D, Pradere J P, et al. Lysophosphatidic acid inhibits adipoeyte differentiation via lysophosphatidic acid 1 receptor-dependent down-regulation of peroxisome proliferator-activated receptor gamma[J]. J Biol Chem, 2005, 280(15) :14656- 14662.
  • 5Fang X, Yu S, Bast R C, et al. Mechanisms for lysophosphatid ic acid-induced cytokion production in ovarian cancer cells[J]. J Bio Chem, 2004, 279(10) :9651-9661.
  • 6Hama K, Aoki J, Fukaya M, et al. Lysophosphatidic acid and autotoxin stimulate cell motility of neoplastic and nonneoplastie cells through LPA1[J]. J Biol Chem, 2004, 279(17):17634-17639.
  • 7Lee Z, Swaby R F, Liang Y, et al. Lysophosphatidic acid is a major regulator of growth regulated oncogene alpha in ovarian cancer[J]. Cancer Res, 2006, 66(5) :2740-2748.
  • 8Chun J, Rosen H. Lysophospholipid receptors as potential drug targets in tissue transplantation and autoimmune diseases[J]. Curr Pharm Des, 2006, 12(2):161 -171.
  • 9Kelley G G, Kaproth-Joslin KA, Reks SE, et al. G protein-cou pied receptor agonists activate endogenous phospholipase Cepsilon and phospholipase C133 in a temporally distinct manner[J]. J Biol Chem, 2006, 281(5),2639-2648.
  • 10Ye X, Hama K, Contos J J, et al. LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing[J]. Na ture, 2005, 435(7038):104-108.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部